News & Events

After the success of the European program REBORNE (FP7) focused on safety and efficacy of the Biomatlante matrix combined with autologous bone marrow expanded mesenchymal stem cells (MSC), MBCP+™, made from our well-known MBCP Technology, was confirmed as the adapted matrix for tissue engineering and chosen for 2 new European research programs (H2020): MAXIBONE and ORTHOUNION.

Coordinated by INSERM (Institut National de la Santé et de la Recherche Médicale) and with the support of the E.U., the REBORNE Program sought to establish the feasibility, relevance and efficacy of the association of MBCP+™*, a synthetic bone graft manufactured by Biomatlante made from MBCP™ Technology, and Mesenchymal Stem Cells (MSCs)1.

Upcoming Events

EUROSPINE 2019

Date: October 16 - 18

Location: Helsinki, Finland

Come and visit us!

Past Events

AAOS 2019

Date: March 12 - 16

Location: Venetian / Sands Expo

Booth #4217

IDS 2019

Date: March 12 - 16

Location: Cologne, Germany

Hall 4.2 | Stand N101

biomatlante-logo-white-color.png
Biomatlante, has been at the forefront of development of new synthetic bone graft.

5 Rue Edouard Belin, 44360 Vigneux-de-Bretagne, France
+33 2 28 02 00 09
Contact@biomatlante.com


Our Products

More Links

© Copyright 2019 Biomatlante. All Rights Reserved.

Search